Exhibit 23.2

INDEPENDENT AUDITORS' CONSENT

Hemispherx Biopharma, Inc.
Philadelphia, Pennsylvania

We hereby consent to the use in the Prospectus constituting a part of this
Registration Statement on Form S-1 of our report dated June 10, 2003, relating
to our audits of the consolidated financial statements and schedule of
Interferon Sciences, Inc. and subsidiary as of December 31, 2002 and 2001 and
for each of the years in the three-year period ended December 31, 2002.

We also consent to the reference to us under the caption "Experts" in the
Prospectus.

/s/ Eisner LLP
--------------
Eisner LLP

New York, New York
December  12, 2003